These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10752624)

  • 1. Role of residue Y99 in tissue plasminogen activator.
    Vindigni A; Winfield M; Ayala YM; Di Cera E
    Protein Sci; 2000 Mar; 9(3):619-22. PubMed ID: 10752624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of P225 and the C136-C201 disulfide bond in tissue plasminogen activator.
    Vindigni A; Di Cera E
    Protein Sci; 1998 Aug; 7(8):1728-37. PubMed ID: 10082369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.
    Rezaie AR
    Biochemistry; 1998 Sep; 37(38):13138-42. PubMed ID: 9748320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a binding site for quaternary amines in factor Xa.
    Monnaie D; Arosio D; Griffon N; Rose T; Rezaie AR; Di Cera E
    Biochemistry; 2000 May; 39(18):5349-54. PubMed ID: 10820005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of tissue plasminogen activator specificity using peptidyl fluorogenic substrates.
    Butenas S; Kalafatis M; Mann KG
    Biochemistry; 1997 Feb; 36(8):2123-31. PubMed ID: 9047311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
    Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
    Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator.
    Björquist P; Brohlin M; Ehnebom J; Ericsson M; Kristiansen C; Pohl G; Deinum J
    Biochim Biophys Acta; 1994 Dec; 1209(2):191-202. PubMed ID: 7811690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
    Lamba D; Bauer M; Huber R; Fischer S; Rudolph R; Kohnert U; Bode W
    J Mol Biol; 1996 Apr; 258(1):117-35. PubMed ID: 8613982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
    Wang Q; Shaltiel S
    BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors.
    Renatus M; Bode W; Huber R; Stürzebecher J; Prasa D; Fischer S; Kohnert U; Stubbs MT
    J Biol Chem; 1997 Aug; 272(35):21713-9. PubMed ID: 9268299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ; Krikun G; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
    Kvassman JO; Verhamme I; Shore JD
    Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator inhibitor 1.
    Thelwell C; Longstaff C
    J Thromb Haemost; 2007 Apr; 5(4):804-11. PubMed ID: 17408411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
    Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.
    Gils A; Knockaert I; Declerck PJ
    Biochemistry; 1996 Jun; 35(23):7474-81. PubMed ID: 8652525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
    Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
    Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin-specific tissue-type plasminogen activator engineered by introduction of the Arg-Gly-Asp sequence.
    Yamada T; Shimada Y; Kikuchi M
    Biochem Biophys Res Commun; 1996 Nov; 228(2):306-11. PubMed ID: 8920910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct contributions of residue 192 to the specificity of coagulation and fibrinolytic serine proteases.
    Zhang YL; Hervio L; Strandberg L; Madison EL
    J Biol Chem; 1999 Mar; 274(11):7153-6. PubMed ID: 10066774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides.
    Heaton JH; Kathju S; Gelehrter TD
    Mol Endocrinol; 1992 Jan; 6(1):53-60. PubMed ID: 1738371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.